医学
导管
外周穿刺中心静脉导管
外科
贵要静脉
静脉
麻醉
作者
Niccolò Buetti,Jonas Marschall,Gaud Catho,Jean‐François Timsit,Leonard A. Mermel
标识
DOI:10.1016/j.cmi.2023.01.014
摘要
Peripherally inserted central venous catheters (PICCs) are frequently used in outpatient and inpatient settings. Recently, midline catheters have emerged as an alternative to PICCs, with an substantial increase in use over the last few years [ [1] Bing S. Smotherman C. Rodriguez R.G. Skarupa D.J. Ra J.H. Crandall M.L. PICC versus midlines: comparison of peripherally inserted central catheters and midline catheters with respect to incidence of thromboembolic and infectious complications. Am J Surg. 2022; 223: 983-987https://doi.org/10.1016/j.amjsurg.2021.09.029 Abstract Full Text Full Text PDF PubMed Scopus (10) Google Scholar ]. Midline catheters have a shorter length and lower surface area, thus reducing the theoretical risk of infectious and non-infectious complications [ [2] Lu H. Hou Y. Chen J. Guo Y. Lang L. Zheng X. et al. Risk of catheter-related bloodstream infection associated with midline catheters compared with peripherally inserted central catheters: a meta-analysis. Nurs Open. 2021; 8: 1292-1300https://doi.org/10.1002/nop2.746 Crossref PubMed Scopus (9) Google Scholar ]. These catheters are 7.5–25 cm in length and usually inserted above the antecubital fossa, with the catheter tip residing in the basilic or cephalic vein just short of the subclavian vein. The recommended duration of midline catheter use is 1–4 weeks, whereas PICCs can remain indwelling for months [ [3] Chopra V. Flanders S.A. Saint S. Woller S.C. O’Grady N.P. Safdar N. et al. The Michigan appropriateness guide for intravenous catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. Ann Intern Med. 2015; 163: S1-S40https://doi.org/10.7326/M15-0744 Crossref PubMed Scopus (388) Google Scholar , [4] Moss J.G. Wu O. Bodenham A.R. Agarwal R. Menne T.F. Jones B.L. et al. Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Lancet. 2021; 398: 403-415https://doi.org/10.1016/S0140-6736(21)00766-2 Abstract Full Text Full Text PDF PubMed Scopus (39) Google Scholar ].
科研通智能强力驱动
Strongly Powered by AbleSci AI